RXO stock: C.H. Robinson’s $30.25 deal has a moving value

C.H. Robinson agreed on October 4 to acquire RXO, and the companies announced the deal on October 5. The number drawing attention is $30.25 per RXO share. For most holders, however, that is a reference value, not a fixed cash payment: the standard election consists of $17.25 in cash and 0.0856 C.H. Robinson shares. Its final dollar value will move with the buyer’s stock until the terms are settled.

The joint announcement filed with the SEC calculated $30.25 using a 16-trading-day volume-weighted average C.H. Robinson price of $151.88 through October 2. TECHi’s calculation is $17.25 + (0.0856 × $151.88) = $30.2509, rounded to $30.25. About $13 of that illustrative amount comes from stock. This distinction matters more to an RXO holder than the headline premium if CHRW moves sharply before closing.

What an RXO share would receive

The RXO merger filing offers holders three elections: the standard $17.25 cash plus 0.0856 CHRW shares, $30.25 all cash, or 0.1992 CHRW shares. The choices are subject to proration so the aggregate consideration remains roughly 57% cash and 43% stock. Choosing cash does not guarantee that every share submitted will be paid entirely in cash. The company’s election materials and the final allocation will govern the actual outcome.

One way to see the stock exposure is to hold every other term constant. A 10% move in CHRW from the $151.88 reference price would change the value of the 0.0856-share component by about $1.30 per RXO share. That is approximately 4.3% of the quoted $30.25 reference amount, before any change in RXO’s standalone market price or the probability of completion. This is a sensitivity calculation, not a forecast of either share price or the eventual payout.

The companies described the transaction as approximately $5.3 billion in equity value and $5.8 billion in enterprise value. Enterprise value includes obligations beyond the equity consideration; it is not a second amount being paid to RXO shareholders.

Why the buyer’s stock also matters

C.H. Robinson says the combination would deepen its truck-brokerage network and generate about $300 million in annual run-rate cost savings within two years after closing. “Run rate” describes a target level once integration is complete; it is neither savings already banked nor a promise that the entire amount will appear in the first post-close year. The buyer presentation also says repurchases will pause until the company gets net debt to adjusted EBITDA within its target range of 1.75 to 2.25 times by the end of 2028.

That trade-off gives CHRW investors a separate question from RXO holders. The buyer gets a larger brokerage operation and a stated cost-cutting opportunity, but will take on financing and integration work while suspending a way it previously returned capital to shareholders. If freight demand or pricing weakens, the hoped-for savings could take longer to offset the financing and integration costs. If the companies combine systems and purchasing effectively, the benefits could become material to future earnings. Neither outcome follows automatically from the announcement.

RXO’s own operating backdrop is relevant. Its September 9 brokerage update said August truckload gross profit per load rose more than 10% from July and that spot freight represented about half of its full-truckload volume through the first two months of the quarter. Those are company-reported operating measures from before the merger announcement, not evidence that the $300 million combined-company savings target is already achieved. They do show why current freight conditions, not just merger arithmetic, deserve a place in the investment case.

The deal spread is not a simple discount coupon

The difference between RXO’s trading price and $30.25 cannot be interpreted as a guaranteed return. The reference amount was fixed using an earlier CHRW average; the standard consideration remains exposed to the buyer’s stock. A holder may also wait until a targeted first-half 2027 close, and the transaction still requires shareholder and regulatory approvals and other conditions. The signed agreement, disclosed in the RXO 8-K, sets out termination provisions and an outside date that can be extended in specified circumstances. A delayed or failed deal would leave RXO trading on its own prospects, not on a guaranteed merger payout.

Investors should therefore compare RXO’s price with the current market value of the applicable consideration, while allowing for proration and closing risk. This article does not use an intraday RXO or CHRW quote: the $151.88 figure is explicitly the transaction’s historical reference average through October 2, not a live October 5 stock price. A changing quote can update the arithmetic, but it cannot remove the approval and execution risks. For a current market check, consult TECHi’s RXO stock page, C.H. Robinson stock page and broader stock market table; use each page’s stated provider and observation time when quotes are available.

The next useful evidence is the definitive shareholder material, the election and proration instructions, any regulatory timetable, and both companies’ subsequent earnings. For CHRW, the measurable test is whether the announced cost savings survive integration without eroding service or loading the balance sheet longer than planned. For RXO, the essential question is what mix of cash and CHRW shares the final allocation actually delivers.